Direct effect of dobutamine on action potential duration in ischemic compared with normal areas in the human ventricle.

BACKGROUND AND OBJECTIVES The arrhythmogenic effect of beta-adrenoceptor stimulation is complex and may differ in ischemic and normal myocardium. In this study we examined the differential effect of beta-adrenergic stimulation on ventricular action potential duration and, hence, dispersion of repolarization in potentially ischemic versus nonischemic human ventricular myocardium. METHODS Simultaneous biventricular monophasic action potentials were recorded in 14 patients (28 recording sites) during infusion of dobutamine in incremental doses (low dose 5 micrograms/kg per min, high dose 10 to 15 micrograms/kg per min) during atrial pacing. Perfusion at the action potential recording site was assessed by incorporating myocardial perfusion scintigraphy with injection of technetium-99m hexakis-2-methoxy-2-methylpropyl-isonitrile during the recording at peak doses of dobutamine. Action potential duration during dobutamine infusion was compared with that during atrial pacing to identical rates in the absence of dobutamine. RESULTS In 21 normal zone recordings, dobutamine produced a variable effect over that produced by atrial pacing to identical heart rates, either lengthening or shortening the action potential duration. The mean (+/- SEM) value for the additional effect of dobutamine was 0.9 +/- 2.5 ms with low doses and -4 +/- 2.6 ms with high doses (p = NS). In seven recordings from potentially ischemic zones, low dose dobutamine had a similar effect (mean change -3.4 +/- 6.5 ms; p = NS vs. normal zone values). However, the high dose dobutamine invariably shortened the action potential duration by a mean of -22.9 +/- 2.9 ms. (p less than 0.05 vs. low dose in ischemic areas, p less than 0.01 vs. normal zone recordings). Pacing alone or the addition of dobutamine had no significant effect on the normal dispersion of action potential duration between two nonischemic recording sites. In recordings in a normal and an abnormally perfused site, high dose dobutamine significantly altered the dispersion of action potential duration. CONCLUSIONS These results suggest a different effect of beta adrenergic stimulation in potentially ischemic compared with nonischemic human ventricular myocardium. The abnormal dispersion of repolarization thus created may well be important in beta-receptor-mediated arrhythmogenesis during myocardial ischemia.

[1]  P. Schwartz,et al.  Sympathetic nervous system and cardiac arrhythmias , 1990 .

[2]  M. Weir,et al.  The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[3]  Capelle,et al.  Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation. , 1991, Circulation research.

[4]  D. Zipes.  Monophasic action potentials in the diagnosis of triggered arrhythmias. , 1991, Progress in cardiovascular diseases.

[5]  P. Taggart,et al.  Interplay between adrenaline and interbeat interval on ventricular repolarisation in intact heart in vivo. , 1990, Cardiovascular research.

[6]  B. Surawicz,et al.  Primary T wave abnormalities caused by uniform and regional shortening of ventricular monophasic action potential in dog. , 1975, Circulation.

[7]  P Taggart,et al.  Simultaneous endocardial and epicardial monophasic action potential recordings during brief periods of coronary artery ligation in the dog: influence of adrenaline, beta blockade and alpha blockade. , 1988, Cardiovascular research.

[8]  M J Lab,et al.  Contraction-excitation feedback in myocardium. Physiological basis and clinical relevance. , 1982, Circulation research.

[9]  E. Genton,et al.  Observations in anticoagulant and thrombolytic therapy in pulmonary embolism. , 1975, Progress in cardiovascular diseases.

[10]  G. Callewaert,et al.  Single cardiac Purkinje cells: general electrophysiology and voltage‐clamp analysis of the pace‐maker current. , 1984, The Journal of physiology.

[11]  Lippincott Williams Wilkins,et al.  The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1991, Circulation.

[12]  D. Durrer,et al.  The Effect of Acute Coronary Artery Occlusion on Subepicardial Transmembrane Potentials in the Intact Porcine Heart , 1977, Circulation.

[13]  P. Sutton,et al.  Monophasic action potential recordings during acute changes in ventricular loading induced by the Valsalva manoeuvre. , 1992, British heart journal.

[14]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[15]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[16]  Peter Taggart,et al.  USE OF MONOPHASIC ACTION POTENTIAL RECORDINGS DURING ROUTINE CORONARY-ARTERY BYPASS SURGERY AS AN INDEX OF LOCALISED MYOCARDIAL ISCHAEMIA , 1986, The Lancet.

[17]  B. Surawicz,et al.  Characteristics and Possible Mechanism of Ventricular Arrhythmia Dependent on the Dispersion of Action Potential Durations , 1983, Circulation.

[18]  Changes of ventricular monophasic action potential duration by stellate ganglion stimulation in dogs. , 1979, Japanese heart journal.

[19]  M. Mitchell,et al.  Electrical properties and response to noradrenaline of individual heart cells isolated from human ventricular tissue. , 1986, Cardiovascular research.

[20]  M R Franz,et al.  Localization of regional myocardial ischemia by recording of monophasic action potentials. , 1984, Circulation.

[21]  G. Moe,et al.  Nonuniform Recovery of Excitability in Ventricular Muscle , 1964, Circulation research.

[22]  F. Ledda,et al.  Effects of noradrenaline and isoprenaline, in combination with α‐ and β‐receptor blocking substances, on the action potential of cardiac Purkinje fibres , 1973, The Journal of physiology.

[23]  M R Franz,et al.  Relation between repolarization and refractoriness in the human ventricle: cycle length dependence and effect of procainamide. , 1992, Journal of the American College of Cardiology.

[24]  R. Kass,et al.  The ionic basis of concentration‐related effects of noradrenaline on the action potential of calf cardiac purkinje fibres. , 1982, The Journal of physiology.

[25]  M. Janse,et al.  Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. , 1989, Physiological reviews.

[26]  B. Surawicz.  Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations? , 1989, Journal of the American College of Cardiology.

[27]  M. Verani,et al.  Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease. , 1988, Journal of the American College of Cardiology.

[28]  S. Priori,et al.  Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation. , 1988, Circulation.

[29]  L. Rydén,et al.  A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. , 1983, The New England journal of medicine.

[30]  N. El-Sherif,et al.  Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog. 13. Correlation of activation and refractory maps. , 1985, Circulation research.

[31]  Allessie,et al.  Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. , 1977, Circulation research.

[32]  Endocardial monophasic action potential recordings for the detection of myocardial ischemia in man: a study using atrial pacing stress and myocardial perfusion scintigraphy. , 1991, American heart journal.